Peer-reviewed journals:

  1. Mladenović, M., Morgan, I., Ilić, N., Saoud, M., Pergal, M. V., Kaluđerović, G. N., & Knežević, N. Ž. (2021). pH-Responsive Release of Ruthenium Metallotherapeutics from Mesoporous Silica-Based Nanocarriers. Pharmaceutics13(4), 460.
  2. Živojević, K., Mladenović, M., Djisalov, M., Mundzic, M., Ruiz-Hernandez, E., Gadjanski, I., & Knežević, N. Ž. (2021). Advanced mesoporous silica nanocarriers in cancer theranostics and gene editing applications. Journal of Controlled Release.
  3. Knežević, N.Ž.; Ilić, N.; Kaluđerović, G.N. Mesoporous Silica Nanoparticles for pH-Responsive Delivery of Iridium Metallotherapeutics and Treatment of Glioblastoma Multiforme. Inorganics 2022, 10, 250

Conference papers:

  1. Nikola Knezevic, Minja Mladenovic, Mirjana Mundzic and Aleksandra Pavlovic, Stimuli-Responsive Mesoporous Silica Nanoparticles for Applications in Cancer Theranostics, 2021 MRS Fall Meeting, Abstract Book, SB03.05.10, November 30 – December 7, 2021. Virtual event.
  2. Minja Mladenovic, Mirjana Mundzic, Aleksandra Pavlovic, Nikola Knezevic, Potential of mesoporous silica nanoparticles for applications in targeted treatmernt of cancer, 5th Congress of the “Serbian Association for Cancer Research – SDIR” with international participation „Translational potential of cancer research in Serbia”, Abstract book, P44, December 3rd, 2021. Virtual event.
  3. Minja Mladenović, Mirjana Mundžić; Aleksandra Pavlović;  Nikola Knežević, Anticancer Applications of Mesoporous Silica Nanoparticles, 7th Nano Today Conference, 16 – 18 November 2021. Virtual event.
  4. N. Ž. Knežević, N. Ilić, G. N. Kaluđerović, Functionalized Mesoporous Silica Nanoparticles for Drug Delivery to Glioblastoma, Multiforme, 22nd IEEE International Conference on Nanotechnology (IEEE-NANO 2022): Book of Abstracts, 4-8 July 2022, Palma de Mallorca, Spain
  5. Nikola Knežević, Minja Mladenović, Mirjana Mundžić, Aleksandra Pavlović, Mila Djisalov, Teodora Knežić, & Ivana Gadjanski. (2023, February 9). Cyclodextrin-Capped Mesoporous Silica-Based Nanomaterials for pH-Responsive Targeted Theranostics of Glioblastoma Multiforme. International meet on pharmaceutics and drug delivery systems (PHARMAMEET2023), Porto, Portugal.

Acknowledgment: This research was supported by the Science Fund of the Republic of Serbia, PROMIS, #6060755.

This website has been made with the financial support of the Science Fund. The BioSense Institute is solely responsible for the content of this publication and this content does not express the attitude of the Science Fund of the Republic of Serbia.

Science Fund

Start typing and press Enter to search

Shopping Cart